Dr. Levent Akduman, MD

Dr. Akduman practices at Quantum Vision Centers in Swansea, Illinois.

Dr. Akduman's NPI, 1245344605, was assigned on August 19, 2006. Dr. Akduman holds Missouri license 103873.

Dr. Akduman's primary practice is Quantum Vision Centers, at 3990 N Illinois St, Swansea, IL 62226. The practice phone is (618) 277-1130.

Dr. Akduman's primary practice is Quantum Vision Centers in Swansea, Illinois. Dr. Akduman is also affiliated with Memorial Hospital in Belleville. The medical group on file is Signify Health. Dmand AI also links Dr. Akduman to 9 more medical groups and 5 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akduman practices, 7 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Akduman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Akduman's licenses on file in 4 states: Missouri, Florida, Illinois and Ohio.

CMS data shows 29,711 Medicare services from Dr. Akduman across 31 procedure codes in 2024, for 1,278 Medicare patients. Medicare paid $3,109,483 for them.

CMS counts 1,278 Medicare patients who saw Dr. Akduman in 2024. The largest group is 75 to 84, with 444 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akduman's median patient age at 73, with 57% women.

In 2024, Dr. Akduman wrote 1,297 Medicare Part D claims for 481 patients. 67% of them were for generic drugs. CMS names the drug for 1,209 of them, across 13 drugs with 11 or more claims each, at $48,229 in total drug cost. In 2023, CMS named 1,273 claims across 19 drugs.

Dr. Akduman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 98 procedures of cataract surgery by Dr. Akduman, more than 74% of the clinicians it reports for that procedure.

Dmand AI links 32 papers to Dr. Akduman, published from 2012 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Tomography, Optical Coherence, Diabetic Retinopathy and Retina. Dr. Akduman has published most often in BMJ Case Rep. Dr. Akduman's most frequent co-authors are Ross B. Chod, MD, Sean Lewis Edelstein, MD and Mohamed F. Abou Shousha, MD.

CMS Open Payments shows 361 general payments to Dr. Akduman from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Allergan Inc. paid the most, $32,469.